MondayNov 03, 2008 4:25 am

Arno Therapeutics, Inc. (OTC BB: ARNI)

Arno Therapeutics, Inc. (OTC BB: ARNI), a clinical-stage biopharmaceutical company, is focused on developing and commercializing innovative products designed to treat cancer patients. AR-67, a novel third-generation camptothecin analogue in Phase I studies, is the company’s lead compound. AR-67 has demonstrated high potency and significantly improved pharmacokinetic properties when compared with marketed second-generation products in its class. For further information, visit the Company's web site at www.arnothera.com.

Continue Reading

MondayNov 03, 2008 4:25 am

Northfield Laboratories, Inc. (NASDAQ: NFLD)

Northfield Laboratories, Inc. (NASDAQ: NFLD), a leading developer of oxygen-carrying red blood cell substitute, is focused on addressing the need for the treatment of life-threatening blood loss when oxygen-carrying fluid is required and red blood cells are not available. The company’s PolyHeme product restores lost blood volume and hemoglobin levels and is able to be administered rapidly in massive amounts. For further information, visit the Company's web site at www.northfieldlabs.com.

Continue Reading

MondayNov 03, 2008 4:24 am

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA)

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) is focused on discovering and developing breakthrough medicines to treat cancer by regulating cell signaling with small molecules. The company has an exclusive license to pioneer technology and patents associated with certain NF-κB treatment methods, as well as the discovery and development of drugs to regulate NF-κB cell-signaling activity. These treatment methods and drugs could be useful in treating certain diseases. For further information, visit the Company's web site at www.ariad.com.

Continue Reading

MondayNov 03, 2008 4:24 am

North Peace Energy Corp. (TSX: NPE CN)

North Peace Energy Corp. (TSX: NPE CN) has an in situ oil sands project in northern Alberta with 86,400 acres of leases bridging the Peace River and Athabasca oil sands areas. The company’s is currently focused on utilizing a robust and proven in-situ recovery method to advance the development of its resources. With no debt and a clean balance sheet, North Peace is poised for significant growth. For further information, visit the Company's web site at www.northpec.ca.

Continue Reading

MondayNov 03, 2008 4:24 am

Argentex Mining Corporation (TSX: ATX CN)

Argentex Mining Corporation (TSX: ATX CN), a junior mineral resource company, has extensive holdings in Argentina's Patagonia region, including its flagship Pinguino property, a new polymetallic discovery located in Santa Cruz province. This property covers an extensive silver-zinc-lead-indium mineralized system discovered by the company about two years ago. Pinguino holds more than eight mineralized zones, a combined strike length of over 60 kilometers (37 miles) and mineralization proven to depth. For further information, visit the Company's web site at www.argentexmining.com.

Continue Reading

MondayNov 03, 2008 4:23 am

Nkwe Platinum Limited (ASX: NKP AU)

Nkwe Platinum Limited (ASX: NKP AU) is an emerging platinum company with a primary focus on mid-level projects and market capitalization. The company has five key project areas with identified mineralization that contain 17M oz of resources spread over 15,000 ha. Nkwe aims to add significant shareholder value through acquiring, exploring, developing and commercializing Platinum Group Elements (PGE) and associated base metal projects in the Bushveld Complex of South Africa. For further information, visit the Company's web site at www.nkweplatinum.com.

Continue Reading

MondayNov 03, 2008 4:23 am

NMT Medical, Inc. (NASDAQ: NMTI)

NMT Medical, Inc. (NASDAQ: NMTI), a leader in the emerging field of structural heart repair, is focused on designing, developing, manufacturing and marketing proprietary implant technologies that allow interventional cardiologists to treat certain structural heart disease through minimally invasive, catheter-based procedures. By working with qualified physicians, the company has provided minimally invasive treatment for an array of cardiac defects for more than two decades. For further information, visit the Company's web site at www.nmtmedical.com.

Continue Reading

MondayNov 03, 2008 4:23 am

Arena Resources, Inc. (NYSE: (TSX: ARD)

Arena Resources, Inc. (NYSE: ARD), an Oklahoma-based oil and gas exploration, development and production company, has its operations focused on Texas, Oklahoma, Kansas and New Mexico. Since the company’s beginning, experienced management executives have aggressively sought to acquire select properties that provide immediate positive cash flow and development opportunities for the future. So far, the company has made acquisitions representing an estimated 55.4 million BOE's (barrel of oil equivalents) and an estimated $1,982.0 billion* in PV-10 (future net revenues discounted 10%). For further information, visit the Company's web site at www.arenaresourcesinc.com.

Continue Reading

MondayNov 03, 2008 4:22 am

Arcan Resources Ltd. (TSX: ARN CN)

Arcan Resources Ltd. (TSX: ARN CN), a high-growth junior producer, has a balanced portfolio of assets positioned in the Deer Mountain, McLeod and Hamburg areas. The company is approximately 75 percent oil weighted and all oil production is greater than 40º API sweet crude. Arcan is a full cycle exploration company through the drill bit and anticipates adding acquisitions that consolidate holdings or accelerate growth. For further information, visit the Company's web site at www.arcanres.com.

Continue Reading

MondayNov 03, 2008 4:22 am

Nile Therapeutics, Inc. (NASDAQ: NLTX)

Nile Therapeutics, Inc. (NASDAQ: NLTX), a clinical-stage biopharmaceutical company, is focused on developing novel products designed to treat cardiovascular disease. CD-NP, the company’s lead compound, is a chimeric natriuretic peptide that is currently in clinical studies for an initial indication of acute decompensated heart failure. Additionally, the company is also developing CU-NP, a chimeric natriuretic peptide, and 2NTX-99, a small molecule with anti-atherothrombotic and nitric oxide donating properties. For further information, visit the Company's web site at www.nilethera.com.

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered